| Endometriosis |
1 |
1 |
| Clinical Guidelines |
0 |
0.99 |
| Otolaryngology |
0 |
0.4 |
| Cancer |
0 |
0.25 |
| Fertility |
0 |
0.21 |
| Laparoscopy |
0 |
0.98 |
| Pain |
0 |
0.21 |
| Pregnancy |
0 |
0.2 |
| Pain Management |
0 |
0.18 |
| Shoulder Pain |
0 |
0.18 |
| Adolescent Medicine |
0 |
0.17 |
| Thyroid Disease |
0 |
0.16 |
| Genomic Medicine |
0 |
0.14 |
| Estrogen |
0 |
0.13 |
| Europe |
0 |
0.13 |
| Gonadotropin-Releasing Hormone (GnRH) Antagonist |
0 |
0.13 |
| Menopause |
0 |
0.13 |
| Ovarian Cancer |
0 |
0.13 |
| Surgery |
0 |
0.13 |
| Thyroid Cancer |
0 |
0.12 |
| Contraception |
0 |
0.1 |
| Ablation |
0 |
0.08 |
| Biomarker |
0 |
0.08 |
| Embryology |
0 |
0.08 |
| Hormonal Contraception |
0 |
0.08 |
| In Vitro Fertilization |
0 |
0.08 |
| Nerve |
0 |
0.08 |
| Infertility Female |
0 |
0.05 |
| Arthritis |
0 |
0.04 |
| Birth |
0 |
0.04 |
| Board Certification |
0 |
0.04 |
| Breast |
0 |
0.04 |
| Cough |
0 |
0.04 |
| Crohn Disease |
0 |
0.04 |
| Endometrioma |
0 |
0.04 |
| Endoscopy |
0 |
0.04 |
| Epigenetics |
0 |
0.04 |
| Epithelium |
0 |
0.04 |
| Evidence-Based Medicine |
0 |
0.04 |
| Florida |
0 |
0.04 |
| Food and Drug Administration (FDA) |
0 |
0.04 |
| Genetics |
0 |
0.04 |
| Gonadotropin-Releasing Hormone (GnRH) Agonists |
0 |
0.04 |
| Health Care Cost |
0 |
0.04 |
| Nodule |
0 |
0.04 |
| Pneumothorax |
0 |
0.04 |
| Postoperative |
0 |
0.04 |
| Primary Care |
0 |
0.04 |
| Progestin |
0 |
0.04 |
| Prognosis |
0 |
0.04 |
| Quality of Life |
0 |
0.04 |
| Reproduction Technology |
0 |
0.04 |
| Rheumatoid Arthritis |
0 |
0.04 |
| Thyroid |
0 |
0.04 |
| Tissue |
0 |
0.04 |
| Travel Medicine |
0 |
0.04 |
| Triage |
0 |
0.04 |
| Ultrasonography |
0 |
0.04 |
| Type 2 Diabetes Mellitus |
0 |
0.03 |